Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
CRISPR is Revolutionizing Cancer Research
Leah Gilstrap on LinkedIn: Antibiotic-resistant bacteria found on space station toilet
Gene-editing technique could speed up study of cancer mutations, MIT News
How CRISPR Is Changing Cancer Research and Treatment - NCI
Genetics LocalHealthGuide
Home – Articles, Analysis, Opinion – The Conversation – page 499
Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy, Molecular Cancer
Frontiers The Off-Targets of Clustered Regularly Interspaced Short Palindromic Repeats Gene Editing
CRISPR/Cas9 Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Genetically modified organism - Wikipedia
Breast cancer – News, Research and Analysis – The Conversation – page 3
Ovarian cancer – News, Research and Analysis – The Conversation – page 1
PDF) CRISPR/Cas9 Technology: Challenges and drawbacks
New Technique Limits CRISPR-Cas9 Off-Target Mutations
Gene-editing technique CRISPR identifies dangerous breast cancer mutations